<SEC-DOCUMENT>0001104659-16-164581-index.html : 20161230 <SEC-HEADER>0001104659-16-164581.hdr.sgml : 20161230 <ACCEPTANCE-DATETIME>20161230162336 ACCESSION NUMBER: 0001104659-16-164581 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161230 FILED AS OF DATE: 20161230 DATE AS OF CHANGE: 20161230 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics AG CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: C4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 BUSINESS PHONE: 43 (0)1 740 93-0 MAIL ADDRESS: STREET 1: LEBERSTRASSE 20 CITY: VIENNA STATE: C4 ZIP: 1110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sender Gary CENTRAL INDEX KEY: 0001659085 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 162077817 MAIL ADDRESS: STREET 1: C/O SYNERGY PHARMACEUTICALS INC. STREET 2: 420 LEXINGTON AVE CITY: NEW YORK STATE: NY ZIP: 10020 </SEC-HEADER> <DOCUMENT> <TYPE>3 <SEQUENCE>1 <FILENAME>a3.xml <DESCRIPTION>3 <TEXT> Document 1 - file: a3.html
Document 1 - RAW XML: a3.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24.1 <SEQUENCE>2 <FILENAME>ex-24d1.htm <DESCRIPTION>EX-24.1 <TEXT> Document 2 - file: ex-24d1.htm
</DOCUMENT> </SEC-DOCUMENT>